Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 20

Showing 20 citing articles:

Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
Yonghao Zhan, Zhenzhen Zhou, Zhaowei Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Materials Today Bio (2024) Vol. 26, pp. 101029-101029
Open Access | Times Cited: 7
Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA
Simin Ye, Shiyu Chen, Xiaoyan Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Recent advances in the construction strategy, functional properties, and biosensing application of self-assembled triangular unit-based DNA nanostructures
Mengxia Duan, Yu‐Ting Chang, Xiaowan Chen, et al.
Biotechnology Advances (2024) Vol. 76, pp. 108436-108436
Closed Access | Times Cited: 4
Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy
Kenneth K.W. To, Hang Zhang, William C. Cho
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4
3D Bioprinted Multidrug Resistance (MDR)-Dependent Tumor Spheroids
M. H. Hong, Sera Hong, Joon Myong Song
ACS Applied Materials & Interfaces (2025)
Closed Access
Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/Vcr Cells
Qin Ouyang, Bo Xu, Tao Yu, et al.
(2025)
Closed Access
In silico identification of multidrug resistance gene (MDR)-targeted transposon miRNAs in human cancer
Seda Mesci
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2025) Vol. 830, pp. 111903-111903
Closed Access
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/VCR Cells
Bo Xu, Tao Yu, Hong-Yuan Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117542-117542
Closed Access
Progress in Research of Nanotherapeutics for Overcoming Multidrug Resistance in Cancer
Ayitila Maimaitijiang, Dongze He, Dingyang Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9973-9973
Open Access | Times Cited: 3
circ_SMA4 promotes gastrointestinal stromal tumors malignant progression by sponging miR-494-3p/KIT axis and activating JAK/STAT pathway
Fangwen Zou, Yifang Tang, Xiaojing Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate
Xinyu Dou, Chunyu Feng, Ji Li, et al.
Trends in Cell Biology (2024)
Closed Access | Times Cited: 2
MicroRNA-486-3p affects cisplatin resistance in high-grade serous ovarian cancer by regulating TMIGD2: An experimental study
Jing Wang, Yanan Wu
Heliyon (2024) Vol. 10, Iss. 15, pp. e34978-e34978
Open Access | Times Cited: 1
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds
Salvatrice Rigogliuso, Alessandra Cusimano, Lucia Condorelli, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1358-1358
Open Access | Times Cited: 1
Integration of Fe(III)-Chelated Polydopamine and Diallyl Trisulfide for Boosting Ferroptosis to Reverse Multidrug Resistance and Inducing Synergistic Tumor Nanotherapy
Yiwang Zhao, Shunyu Yao, Jing Huang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 22, pp. 25580-25592
Closed Access | Times Cited: 1
Editorial: ABC transporters and drug resistance
Qisi Lu, Suresh V. Ambudkar, Dong‐Hua Yang
Drug Resistance Updates (2024) Vol. 77, pp. 101135-101135
Closed Access
Involvement of everolimus‑induced ABCB1 downregulation in drug‑drug interactions
Yuko Nakayama, Aya Ino, Kazuhiro Yamamoto, et al.
Biomedical Reports (2024) Vol. 21, Iss. 6
Open Access
Post-translational modifications in drug resistance
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access
MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters
Xinyan Lu, Hongxu Jin
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top